MeSH tree: C14.907.454.460
Researchers at the VIB-UGent Center for Medical Biotechnology have discovered a promising strategy to improve treatment responses in multiple myeloma patients by blocking a protein that plays a key role in drug resistance. ...
Apr 15, 2025
0
16
Researchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis, prognosis, and therapeutic management of multiple myeloma. This new study in The Journal of Molecular ...
Apr 14, 2025
0
21
A new study conducted by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore has uncovered a key mechanism behind lenalidomide resistance in multiple myeloma ...
Apr 10, 2025
0
19
A clinical team has spearheaded the use of CAR-T cell therapy for blood cancers. The researchers recently treated the first myeloma patient with this therapy, resulting in a very good response without severe complications. ...
Mar 27, 2025
0
23
Researchers at the University of Colorado Anschutz Medical Campus have successfully developed a supercharged iteration of CAR-T cell therapy that can enhance the effectiveness and longevity of the cells, particularly against ...
Mar 10, 2025
0
41
Researchers have discovered and analyzed a rare but serious side effect of an innovative form of blood cancer therapy. The scientists from the University of Leipzig Medical Center, the Fraunhofer Institute for Cell Therapy ...
Feb 21, 2025
0
32
Genetic testing should be used to help doctors spot high-risk cases of myeloma and enable targeted treatments, say researchers from the University of Leeds and The Institute of Cancer Research.
Feb 20, 2025
0
17
The American Cancer Society (ACS) has released Cancer Statistics for African American and Black People, 2025. According to the report, the cancer mortality rate declined from 1991 to 2022 by 49% and 33% in Black men and women, ...
Feb 20, 2025
0
14
When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, report researchers from Berlin and Heidelberg in Science Immunology. The detailed ...
Feb 10, 2025
0
48
For patients with newly diagnosed multiple myeloma (NDMM) receiving dexamethasone induction, dose reductions do not negatively impact survival, according to a study published online Jan. 2 in Blood.
Jan 24, 2025
0
17
